244 related articles for article (PubMed ID: 36945256)
21. "Sweet tooth"-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy.
Ding N; Xu S; Zheng S; Ye Q; Xu L; Ling S; Xie S; Chen W; Zhang Z; Xue M; Lin Z; Xu X; Wang L
J Mater Chem B; 2021 Mar; 9(12):2816-2830. PubMed ID: 33690741
[TBL] [Abstract][Full Text] [Related]
22. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38.
Bala V; Rao S; Boyd BJ; Prestidge CA
J Control Release; 2013 Nov; 172(1):48-61. PubMed ID: 23928356
[TBL] [Abstract][Full Text] [Related]
23. Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities.
Zuo S; Sun B; Yang Y; Zhou S; Zhang Y; Guo M; Sun M; Luo C; He Z; Sun J
Small; 2020 Nov; 16(45):e2005039. PubMed ID: 33078579
[TBL] [Abstract][Full Text] [Related]
24. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
[TBL] [Abstract][Full Text] [Related]
25. Redox responsive 7-ethyl-10-hydroxycamptothecin (SN38) lysophospholipid conjugate: synthesis, assembly and anticancer evaluation.
He W; Du Y; Wang T; Wang J; Cheng L; Li X
Int J Pharm; 2021 Sep; 606():120856. PubMed ID: 34229071
[TBL] [Abstract][Full Text] [Related]
26. Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors.
Zhang M; Zhang F; Liu T; Shao P; Duan L; Yan J; Mu X; Jiang J
Int J Nanomedicine; 2020; 15():10183-10197. PubMed ID: 33363374
[TBL] [Abstract][Full Text] [Related]
27. Kinetically-stable small-molecule prodrug nanoassemblies for cancer chemotherapy.
Zheng Y; Ying X; Su Y; Jin X; Xu Q; Li Y
Int J Pharm; 2021 Mar; 597():120369. PubMed ID: 33577910
[TBL] [Abstract][Full Text] [Related]
28. Probing the fluorination effect on the self-assembly characteristics,
Wang X; Yang B; Li L; Liu T; Zuo S; Chi D; He Z; Sun B; Sun J
Theranostics; 2021; 11(16):7896-7910. PubMed ID: 34335971
[No Abstract] [Full Text] [Related]
29. Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy.
Wang J; Sun X; Mao W; Sun W; Tang J; Sui M; Shen Y; Gu Z
Adv Mater; 2013 Jul; 25(27):3670-6. PubMed ID: 23740675
[TBL] [Abstract][Full Text] [Related]
30. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.
Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z
J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976
[TBL] [Abstract][Full Text] [Related]
31. Actively targeted delivery of SN38 by ultrafine iron oxide nanoparticle for treating pancreatic cancer.
Xue T; Xu P; Padelford J; Xue X; Wu AY; Li Y; Wang L
Invest New Drugs; 2022 Jun; 40(3):546-555. PubMed ID: 35290548
[TBL] [Abstract][Full Text] [Related]
32. SN38-based albumin-binding prodrug for efficient targeted cancer chemotherapy.
Huang Y; Wang L; Cheng Z; Yang B; Yu J; Chen Y; Lu W
J Control Release; 2021 Nov; 339():297-306. PubMed ID: 34619226
[TBL] [Abstract][Full Text] [Related]
33. Functionalized Nanoparticles Efficiently Enhancing the Targeted Delivery, Tumor Penetration, and Anticancer Activity of 7-Ethyl-10-Hydroxycamptothecin.
Liu X; Si J; Zhang Q; Huang Q; Gu D; Yang H; Chen X; Shen Y; Sui M
Adv Healthc Mater; 2018 Apr; 7(7):e1701140. PubMed ID: 29334179
[TBL] [Abstract][Full Text] [Related]
34. Active targeting redox-responsive mannosylated prodrug nanocolloids promote tumor recognition and cell internalization for enhanced colon cancer chemotherapy.
Gao Y; Qiu W; Liang M; Ma X; Ye M; Xue P; Kang Y; Deng J; Xu Z
Acta Biomater; 2022 Jul; 147():299-313. PubMed ID: 35640802
[TBL] [Abstract][Full Text] [Related]
35. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
Li Y; Lu H; Liang S; Xu S
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
[TBL] [Abstract][Full Text] [Related]
36. Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H
Mu X; Huang Z; Feng W; Zhai M; Wang Y; Zhou D; Zhou X
Theranostics; 2023; 13(1):267-277. PubMed ID: 36593965
[No Abstract] [Full Text] [Related]
37. Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin.
Si J; Zhao X; Gao S; Huang D; Sui M
Int J Pharm; 2019 Sep; 568():118499. PubMed ID: 31299338
[TBL] [Abstract][Full Text] [Related]
38. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
[TBL] [Abstract][Full Text] [Related]
39. Monodisperse oligoethylene glycols modified Camptothecin, 10-Hydroxycamptothecin and SN38 prodrugs.
Deng T; Mao X; Xiao Y; Yang Z; Zheng X; Jiang ZX
Bioorg Med Chem Lett; 2019 Feb; 29(4):581-584. PubMed ID: 30600208
[TBL] [Abstract][Full Text] [Related]
40. Ultrasound-Triggered Piezocatalysis for Selectively Controlled NO Gas and Chemodrug Release to Enhance Drug Penetration in Pancreatic Cancer.
Wang Y; Tang Q; Wu R; Sun S; Zhang J; Chen J; Gong M; Chen C; Liang X
ACS Nano; 2023 Feb; 17(4):3557-3573. PubMed ID: 36775922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
